- Merck & Co. (Boston, MA)
- …imaging strategy for application of novel PET tracers in early clinical oncology trials, guiding projects from late -stage preclinical work through clinical ... Imaging Scientist to lead the transition of novel PET radiotracers from late preclinical development into first-in-human studies. This role will primarily focus on… more
- Parexel (Boston, MA)
- …World Data) + Medical affairs experience (Phase IIIB - IV trials experience); Late Phase Oncology + Strong project management experience + Demonstrated ... **Job Title:** Data Management Lead (Medical Affairs) - Oncology **Location:** Fully Remote (US based) Must be able to accommodate West Coast hours. **About Us:** At… more
- Pfizer (Cambridge, MA)
- …trial(s) in support of the development strategy for programs within the Late -Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for ... similar role in industry/CRO + Clinical Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and with a track record of… more
- Pfizer (Cambridge, MA)
- …+ Medical degree with 5+ years of industry experience + Clinical oncology experience (typically 4+ years) **Preferred Qualifications** Board certified/eligible in ... oncology or equivalent preferred Breast Oncology experience (2+ years) **Organizational Relationships** Reports to Global Development Lead and partners closely… more
- Takeda Pharmaceuticals (Boston, MA)
- …be to drive efficient and effective CDx strategy execution for early- and late -stage Oncology programs. Key responsibilities include development and delivery of ... vital contributor to our inspiring, bold mission. OBJECTIVES: The Oncology Companion Diagnostic Program Manager (CDx PM) role is...PM) role is an exciting new opportunity within the Oncology Therapeutic Area Unit (OTAU) at Takeda. The primary… more
- Sumitomo Pharma (Boston, MA)
- …Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology , urology, women's health, rare diseases, psychiatry & neurology, and cell & ... and Europe, and a diverse pipeline of early- to late -stage assets, we aim to accelerate discovery, research, and...leader for the position of **Vice President, Regulatory Affairs Oncology ** . The candidate must be deeply experienced in… more
- Takeda Pharmaceuticals (Boston, MA)
- …by our OneOncology vision, we are advancing a rapidly growing oncology portfolio with potentially first-in-class and best-in-class therapies, including antibody-drug ... Takeda as a Senior Director, Global Regulatory Lead - Oncology , where you will be part of the global...set global regulatory direction, provide expert guidance, and lead late -stage projects to ensure innovative and robust strategies are… more
- Bristol Myers Squibb (Cambridge, MA)
- …careers.bms.com/working-with-us . Bristol Myers Squibb has pioneered the development of immuno- oncology therapies and continues to diversify in drug development for ... be responsible for development and execution of translational strategies in solid tumor oncology for assigned programs. Key responsibilities of this role are to act… more
- Takeda Pharmaceuticals (Boston, MA)
- …**:** Responsible for leading as the Global Clinical Lead a large solid tumor oncology franchise that encompass multiple late stage and early phase programs . ... + **Clinical Development team participation and leadership** + Accountable to Oncology Clinical Science Head to provide strategic clinical input on assigned… more
- Sumitomo Pharma (Boston, MA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Boston, MA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Boston, MA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Astellas Pharma (Cambridge, MA)
- …development and execution of Translational Medicine strategy to advance Astellas' Oncology projects. Candidates should have deep expertise in ophthalmology, vision ... record of accomplishment in developing and executing translational strategy from late discovery through clinical development. Ability to represent the TM function… more
- Bristol Myers Squibb (Cambridge, MA)
- …a robust enterprise level strategy for asset(s) and indication(s) including early, late and post-marketing development, as well as awareness of the enterprise ... through proof of concept trials and will to assure a seamless transition into late stage development (Phase II-III trials) + Ability to lead and develop a group… more
- Merck (Boston, MA)
- …imaging strategy for application of novel PET tracers in early clinical oncology trials, guiding projects from late -stage preclinical work through clinical ... Imaging Scientist to lead the transition of novel PET radiotracers from late preclinical development into first-in-human studies. This role will primarily focus on… more
- Sumitomo Pharma (Boston, MA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Boston, MA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Boston, MA)
- …Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology , urology, women's health, rare diseases, psychiatry & neurology, and cell & ... and Europe, and a diverse pipeline of early- to late -stage assets, we aim to accelerate discovery, research, and...Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene… more
- Sumitomo Pharma (Boston, MA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research,...position will report to the **Director, Commercial Analytics - Oncology ** and will be an integral part of the… more
- Sumitomo Pharma (Boston, MA)
- …Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology , urology, women's health, rare diseases, psychiatry & neurology, and cell & ... in the US, Canada, and Europe, and a diverse pipeline of early- to late -stage assets, we aim to accelerate discovery, research, and development to bring novel… more
